United States · Platforms & data · MarketBeat

What Travere Therapeutics (TVTX) Said on Its Q3 Earnings Call

Published by MarketBeat · United States 2 h ago

Travere Therapeutics (NASDAQ:TVTX) reported third-quarter results marked by record FILSPARI sales, continued early adoption in focal segmental glomerulosclerosis (FSGS), and…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

The Motley Fool

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

MarketWatch

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Investing.com

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

CNBC

Stock market after midterm elections: What S&P 500 history shows

TipRanks